Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
3.530
+0.330 (10.31%)
At close: Apr 25, 2025, 4:00 PM
3.510
-0.020 (-0.57%)
After-hours: Apr 25, 2025, 4:19 PM EDT

Mainz Biomed Statistics

Total Valuation

Mainz Biomed has a market cap or net worth of $10.73 million. The enterprise value is $7.76 million.

Market Cap 10.73M
Enterprise Value 7.76M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, before market open.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

Mainz Biomed has 3.04 million shares outstanding. The number of shares has increased by 138.45% in one year.

Current Share Class 3.04M
Shares Outstanding 3.04M
Shares Change (YoY) +138.45%
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.69%
Owned by Institutions (%) 1.54%
Float 2.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.82
Forward PS 7.01
PB Ratio 1.35
P/TBV Ratio 3.54
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.68
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.54.

Current Ratio 1.32
Quick Ratio 1.08
Debt / Equity 0.54
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.13

Financial Efficiency

Return on equity (ROE) is -465.82% and return on invested capital (ROIC) is -115.18%.

Return on Equity (ROE) -465.82%
Return on Assets (ROA) -80.37%
Return on Invested Capital (ROIC) -115.18%
Return on Capital Employed (ROCE) -252.70%
Revenue Per Employee $34,384
Profits Per Employee -$832,718
Employee Count 26
Asset Turnover 0.06
Inventory Turnover 0.65

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.18% in the last 52 weeks. The beta is 0.53, so Mainz Biomed's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change -90.18%
50-Day Moving Average 4.35
200-Day Moving Average 8.64
Relative Strength Index (RSI) 48.14
Average Volume (20 Days) 104,949

Short Selling Information

The latest short interest is 69,425, so 2.28% of the outstanding shares have been sold short.

Short Interest 69,425
Short Previous Month 135,205
Short % of Shares Out 2.28%
Short % of Float 2.52%
Short Ratio (days to cover) 0.53

Income Statement

In the last 12 months, Mainz Biomed had revenue of $893,991 and -$21.65 million in losses. Loss per share was -$22.36.

Revenue 893,991
Gross Profit 574,883
Operating Income -18.42M
Pretax Income -26.30M
Net Income -21.65M
EBITDA -17.71M
EBIT -18.42M
Loss Per Share -$22.36
Full Income Statement

Balance Sheet

The company has $6.24 million in cash and $3.27 million in debt, giving a net cash position of $2.96 million or $0.98 per share.

Cash & Cash Equivalents 6.24M
Total Debt 3.27M
Net Cash 2.96M
Net Cash Per Share $0.98
Equity (Book Value) 6.05M
Book Value Per Share 2.61
Working Capital 1.89M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.09 million and capital expenditures -$104,949, giving a free cash flow of -$17.19 million.

Operating Cash Flow -17.09M
Capital Expenditures -104,949
Free Cash Flow -17.19M
FCF Per Share -$5.66
Full Cash Flow Statement

Margins

Gross Margin 64.31%
Operating Margin -2,060.23%
Pretax Margin -2,421.80%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mainz Biomed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -138.45%
Shareholder Yield n/a
Earnings Yield -201.83%
FCF Yield -160.29%

Analyst Forecast

The average price target for Mainz Biomed is $14.00, which is 296.60% higher than the current price. The consensus rating is "Buy".

Price Target $14.00
Price Target Difference 296.60%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 143.03%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 3, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date Dec 3, 2024
Split Type Reverse
Split Ratio 0.025:1

Scores

Mainz Biomed has an Altman Z-Score of -12.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.85
Piotroski F-Score 4